Author

L. S. Pongor

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:chromatin & epigenetic regulation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

A. A. Wang· 1 shared A. Gellert· 1 shared A. Saiakhova· 1 shared A. Szigeti· 1 shared A. Thomas· 1 shared A. Vingiani· 1 shared B. Gyorffy· 1 shared B. Miwatani-Minter· 1 shared

Activity by Year

2017-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. A. Wang

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

D-type cyclins regulate DNA mismatch repair in the G1 and S phases of the cell cycle, maintaining genome stability

G. Rona, B. Miwatani-Minter, Q. Zhang, H. V. Goldberg, M. A. Kerzhnerman, J. B. Howard, D. Simoneschi, E. Lane, J. W. Hobbs, E. Sassani, A. A. Wang, S. Keegan, D. J. Laverty, C. G. Piett, L. S. Pongor, , M. Pagano

This study shows D-type cyclins inhibit mismatch repair (MMR) in G1 phase by shielding p21, while their degradation in S phase enables proper MMR function, maintaining genome stability.

bioRxiv · Jan 12, 2024Cell Biology

Epigenetic Regulation Explains The Functionality Behind Colon Cancer Specific Biomarker Septin9

L. Vizkeleti, C. Kiss, V. Tisza, A. Szigeti, A. Gellert, I. Csabai, L. S. Pongor, S. Spisak

This study investigates the epigenetic regulation of Septin9 variants in colorectal cancer, finding hypermethylation at the v2 promoter leads to alternative transcription and potential functional differences.

bioRxiv · Jan 31, 2023 · PreprintCancer Biology

Enhancers mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer.

D. Patten, G. Corleone, B. Gyorffy, E. Erdos, A. Saiakhova, K. Goddard, A. Vingiani, S. Shousha, L. S. Pongor, D. Hadjiminas, G. Schiavon, P. Barry, C. Palmieri, C. Coombes, P. Scacheri, , L. Magnani

This study maps enhancers in luminal breast cancer to reveal phenotypic heterogeneity and its evolutionary dynamics during treatment.

bioRxiv · Sep 26, 2017Cancer Biology